Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 12:12:11-19.
doi: 10.2174/1874613601812010011. eCollection 2018.

Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients

Yee Shan Low  1 , Farida Islahudin  1 , Kamarul Azahar Mohd Razali  2 , Shafnah Adnan  2
Affiliations

Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients

Yee Shan Low et al. Open AIDS J. .

Abstract

Background: Treatment options among Human Immunodeficiency Virus (HIV)-infected children are limited as only a few Highly Active Antiretroviral Therapy (HAART) are approved worldwide for paediatric use. Among children, frequent changes in HAART regimen can rapidly exhaust treatment options, and information addressing this issue is scarce.

Objective: The aim of the study was to determine factors associated with the modification of initial HAART regimen modification among HIV-infected children.

Method: A retrospective study was performed among HIV-infected children aged 18 and below, that received HAART for at least six months in a tertiary hospital in Malaysia. Factors associated with modification of initial HAART regimen were investigated.

Results: Out of 99 patients, 71.1% (n=71) required initial HAART regime modification. The most common reason for HAART modification was treatment failure (n=39, 54.9%). Other reasons included drug toxicity (n=14, 19.7%), change to fixed-dose products (n=11, 15.5%), product discontinuation (n=4, 5.6%) and intolerable taste (n=3, 4.2%). The overall mean time retention on initial HAART before regimen modification was 3.32 year ± 2.24 years (95% CI, 2.79-3.85). Patient's adherence was the only factor associated with initial regimen modification in this study. Participants with poor adherence showed a five-fold risk of having their initial HAART regimen modified compared to those with good adherence (adjusted OR [95% CI], 5.250 [1.614 - 17.076], p = 0.006).

Conclusion: Poor adherence was significantly associated with initial regimen modification, intervention to improve patient's adherence is necessary to prevent multiple regimen modification among HIV-infected children.

Keywords: HAART; HIV; Highly active antiretroviral therapy; Intolerable taste; Malaysia; Paediatric; Regimen modification.

PubMed Disclaimer

References

    1. UNAIDS. Fact Sheet. Geneva: Joint United Nations Programme on HIV/AIDS; 2016.
    1. Global AIDS response progress report. country responses to HIV/AIDS. HIV/STI Section, Disease Control Division. Malaysia: Ministry of Health Malaysia; 2016.
    1. Mocroft A., Ledergerber B., Katlama C., Kirk O., Reiss P., d’Arminio Monforte A., Knysz B., Dietrich M., Phillips A.N., Lundgren J.D. Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet. 2003;362(9377):22–29. doi: 10.1016/S0140-6736(03)13802-0. - DOI - PubMed
    1. Colvin C.J. HIV/AIDS, chronic diseases and globalisation. Global. Health. 2011;7:31. doi: 10.1186/1744-8603-7-31. - DOI - PMC - PubMed
    1. Waning B., Diedrichsen E., Jambert E., Bärnighausen T., Li Y., Pouw M., Moon S. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatr. 2010;10:74. doi: 10.1186/1471-2431-10-74. - DOI - PMC - PubMed

LinkOut - more resources